Drug companies and patient groups want faster approval for cancer drugs

By Dan Harrison
Updated April 21 2015 - 4:18pm, first published 3:45pm

Patient groups are calling for changes to fast track the approval and subsidy of cancer medicines, saying cancer sufferers haven't got time to wait for duplicate testing.

Subscribe now for unlimited access.

$0/

(min cost $0)

or signup to continue reading

See subscription options

Get the latest Eden news in your inbox

Sign up for our newsletter to stay up to date.

We care about the protection of your data. Read our Privacy Policy.